Retractable Technologies
RVP
#10104
Rank
ยฃ18.42 M
Marketcap
ยฃ0.62
Share price
0.61%
Change (1 day)
26.67%
Change (1 year)
Categories

Revenue for Retractable Technologies (RVP)

Revenue in 2025 (TTM): ยฃ28.99 Million

According to Retractable Technologies's latest financial reports the company's current revenue (TTM ) is ยฃ28.64 Million. In 2024 the company made a revenue of ยฃ26.33 Million a decrease over the revenue in the year 2023 that were of ยฃ34.22 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Retractable Technologies from 2001 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ28.99 M10.09%
2024 ยฃ26.33 M-23.04%
2023 ยฃ34.22 M-56.34%
2022 ยฃ78.37 M-43.84%
2021 ยฃ0.13 B132.38%
2020 ยฃ60.05 M88.42%
2019 ยฃ31.87 M21.59%
2018 ยฃ26.21 M2.71%
2017 ยฃ25.52 M5.58%
2016 ยฃ24.17 M21.22%
2015 ยฃ19.94 M-10.06%
2014 ยฃ22.17 M18.8%
2013 ยฃ18.66 M-10.34%
2012 ยฃ20.81 M0.78%
2011 ยฃ20.65 M-11.97%
2010 ยฃ23.46 M-2.6%
2009 ยฃ24.08 M26.55%
2008 ยฃ19.03 M43.85%
2007 ยฃ13.23 M2.36%
2006 ยฃ12.92 M-8%
2005 ยฃ14.05 M25.36%
2004 ยฃ11.21 M5.11%
2003 ยฃ10.66 M-15.83%
2002 ยฃ12.67 M13.79%
2001 ยฃ11.13 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ICU Medical
ICUI
ยฃ1.74 B 5,980.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
ยฃ16.05 B 55,940.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
ยฃ0.75 B 2,538.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Insulet
PODD
ยฃ1.89 B 6,508.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
ยฃ0.13 B 382.11%๐Ÿ‡บ๐Ÿ‡ธ USA